Karlheinz Schmelig

Karlheinz Schmelig is a seasoned professional with extensive experience in the venture capital and biotechnology sectors. Since 2004, Karlheinz has served as Managing Partner at Creathor Ventures, focusing on investments in innovative healthcare and technology companies. Current board positions include Observer roles at Acousia Therapeutics GmbH, CryoTherapeutics GmbH, and Tacalyx GmbH, along with former memberships on the Supervisory Board of Phenex Pharmaceuticals AG and Board Member roles at CEVEC Pharmaceuticals GmbH, Blueprint Genetics, and caprotec bioanalytics. Educational qualifications include an MBA from Indiana University - Kelley School of Business and a Bachelor of Business Administration from Baden-Wuerttemberg Cooperative State University.